Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the fourteen analysts that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $24.92.
A number of equities analysts recently commented on the company. Barclays reduced their price objective on Privia Health Group from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Monday, May 20th. TD Cowen dropped their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating for the company in a report on Friday, March 1st. Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. UBS Group dropped their price target on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, March 1st. Finally, Truist Financial cut their price target on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a report on Wednesday, May 15th.
View Our Latest Report on PRVA
Insider Buying and Selling
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of PRVA. Park Place Capital Corp lifted its position in shares of Privia Health Group by 115.4% during the 1st quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after purchasing an additional 1,335 shares during the last quarter. Benjamin Edwards Inc. lifted its holdings in Privia Health Group by 44.9% during the 4th quarter. Benjamin Edwards Inc. now owns 3,239 shares of the company’s stock worth $75,000 after buying an additional 1,003 shares during the last quarter. Covestor Ltd lifted its holdings in Privia Health Group by 25.5% during the 1st quarter. Covestor Ltd now owns 5,292 shares of the company’s stock worth $104,000 after buying an additional 1,076 shares during the last quarter. SG Americas Securities LLC acquired a new position in shares of Privia Health Group during the 1st quarter worth about $131,000. Finally, Benjamin F. Edwards & Company Inc. purchased a new position in shares of Privia Health Group in the 4th quarter valued at about $158,000. 94.48% of the stock is owned by institutional investors and hedge funds.
Privia Health Group Stock Performance
NASDAQ PRVA opened at $16.48 on Friday. The business has a fifty day moving average price of $17.52 and a 200 day moving average price of $19.84. The company has a market cap of $1.97 billion, a P/E ratio of 109.87, a P/E/G ratio of 2.61 and a beta of 0.78. Privia Health Group has a one year low of $15.92 and a one year high of $28.23.
Privia Health Group (NASDAQ:PRVA – Get Free Report) last issued its earnings results on Thursday, May 9th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). The business had revenue of $415.24 million during the quarter, compared to analyst estimates of $435.07 million. Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. As a group, sell-side analysts predict that Privia Health Group will post 0.2 EPS for the current fiscal year.
About Privia Health Group
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Articles
- Five stocks we like better than Privia Health Group
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- What is the Australian Securities Exchange (ASX)
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Which Wall Street Analysts are the Most Accurate?
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.